Barbara Balicka-Slusarczyk
- Expression of transforming growth factor β (TGFβ) receptor, CD105, is declined in Th1 interstitial lung diseases (ILDs)By Andrzej Dyczek, Jerzy Szczeklik, Barbara Balicka-Slusarczyk, Joanna Chorostowska, Adam Szpechcinski, Ewelina Pόlgesek, Marek Jankowski and Piotr KopinskiAndrzej Dyczek1II Dept of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandJerzy Szczeklik1II Dept of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandBarbara Balicka-Slusarczyk2Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Krakόw, PolandJoanna Chorostowska3Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandAdam Szpechcinski3Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandEwelina Pόlgesek4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMarek Jankowski4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL formBy Piotr Kopinski, Andrzej Dyczek, Barbara Balicka-Slusarczyk, Grzegorz Przybylski, Joanna Chorostowska-Wynimko, Adam Szpechcinski, Teresa Iwaniec, Karina Szablowska and Jerzy SzczeklikPiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAndrzej Dyczek2II Dept of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakόw, PolandBarbara Balicka-Slusarczyk3Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Krakόw, PolandGrzegorz Przybylski5Dept of Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJoanna Chorostowska-Wynimko4Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandAdam Szpechcinski4Laboratory of Molecular Diagnostics and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandTeresa Iwaniec1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandKarina Szablowska1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandJerzy Szczeklik3Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Krakόw, Poland
- Mechanisms of impaired immune surveillance in lower airways of smokers. Data from bronchoalveolar lavage (BAL) harvested in selected interstitial lung diseases (ILDs) and control groupBy Piotr Kopinski, Andrzej Dyczek, Grzegorz Przybylski, Barbara Balicka-Slusarczyk, Agnieszka Jarzemska, Tomasz Wandtke, Ewelina Pόlgesek and Magda IgielskaPiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAndrzej Dyczek2II Dept of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakόw, PolandGrzegorz Przybylski3Dept of Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandBarbara Balicka-Slusarczyk4Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Krakόw, PolandAgnieszka Jarzemska3Dept of Lung Diseases and Tuberculosis, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandTomasz Wandtke1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandEwelina Pόlgesek1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandMagda Igielska1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulationBy Andrzej Dyczek, Barbara Balicka-Slusarczyk, Jerzy Szczeklik, Grzegorz Przybylsski, Agnieszka Jarzemska, Karina Szablowska, Tomasz Wandtke and Piotr KopinskiAndrzej Dyczek1Dept of Internal Medicine, Centre of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandBarbara Balicka-Slusarczyk2Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Kraków, PolandJerzy Szczeklik2Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Kraków, PolandGrzegorz Przybylsski3Dept of Lung Diseases @ Tumors, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandAgnieszka Jarzemska3Dept of Lung Diseases @ Tumors, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandKarina Szablowska4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandTomasz Wandtke4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, PolandPiotr Kopinski4Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
- Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD)By Piotr Kopinski, Joanna Chorostowska-Wynimko, Andrzej Dyczek, Teresa Iwaniec, Ada Rozy, Paulina Jagus, Karina Szablowska, Tomasz Wandtke and Barbara Balicka-SlusarczykPiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nikolaus Copernicus University, Bydgoszcz, PolandJoanna Chorostowska-Wynimko2Lab of Molecular Biology and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandAndrzej Dyczek3Dept of Internal Medicine, Collegium Medicum, Jagiellonian University, Krakow, PolandTeresa Iwaniec3Dept of Internal Medicine, Collegium Medicum, Jagiellonian University, Krakow, PolandAda Rozy2Lab of Molecular Biology and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandPaulina Jagus2Lab of Molecular Biology and Immunology, Institute of Tuberculosis and Lung Diseases, Warszawa, PolandKarina Szablowska1Dept of Gene Therapy, Collegium Medicum, Nikolaus Copernicus University, Bydgoszcz, PolandTomasz Wandtke1Dept of Gene Therapy, Collegium Medicum, Nikolaus Copernicus University, Bydgoszcz, PolandBarbara Balicka-Slusarczyk4Dept of Environmental Diseases and Toxicology, Collegium Medicum, Jagiellonian University, Krakow, Poland
- Interferon γ (IFNγ) decreases apoptosis rate of antigen primed T helper lymphocytes from bronchoalveolar lavage (BAL)By Piotr Kopinski, Joanna Chorostowska-Wynimko, Andrzej Dyczek, Barbara Balicka-Slusarczyk, Ewelina Pólgesek, Adriana Rozy, Teresa Iwaniec and Tomasz WandtkePiotr Kopinski1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus, Bydgoszcz, PolandJoanna Chorostowska-Wynimko2II Dept. of Internal Medicine, Center of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandAndrzej Dyczek3Dept. of Molecular Biology and Immunology, Inst. of Tuberculosis and Lung Diseases, Warszawa, PolandBarbara Balicka-Slusarczyk4Dept of Toxicology and Environmental Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandEwelina Pólgesek1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus, Bydgoszcz, PolandAdriana Rozy2II Dept. of Internal Medicine, Center of Immunological Diseases, Collegium Medicum, Jagiellonian University, Krakow, PolandTeresa Iwaniec3Dept. of Molecular Biology and Immunology, Inst. of Tuberculosis and Lung Diseases, Warszawa, PolandTomasz Wandtke1Dept of Gene Therapy, Collegium Medicum, Nicolaus Copernicus, Bydgoszcz, Poland
- The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controlsBy Piotr Kopinski, Andrzej Dyczek, Barbara Balicka-Slusarczyk, Grzegorz Przybylski, Ewelina Wedrowska, Joanna Golinska and Joanna Chorostowska-WynimkoPiotr Kopinski1Dept of Gene Therapy, Collegium Medicum UMK, Bydgoszcz, PolandAndrzej Dyczek2Dept of Cardiac Surgery, Anaestesiology & Experimental Cardiology, Collegium Medicum, Jagiellonian University, Krakow, PolandBarbara Balicka-Slusarczyk3Dept of Toxicology & Environmental Medicine, Collegium Medicum, Jagiellonian University, Krakow, PolandGrzegorz Przybylski4Dept of Lung Diseases, Tumors & Tuberculosis, Collegium Medicum UMK, Bydgoszcz, PolandEwelina Wedrowska1Dept of Gene Therapy, Collegium Medicum UMK, Bydgoszcz, PolandJoanna Golinska1Dept of Gene Therapy, Collegium Medicum UMK, Bydgoszcz, PolandJoanna Chorostowska-Wynimko5Dept of Genetics & Clinical Immunology, Inst. of Tuberculosis & Lung Diseases, Warszawa, Poland
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
